Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia

Sharman, Jeff P. ; Egyed, Miklos ; Jurczak, Wojciech ; Skarbnik, Alan ; Pagel, John M. ; Flinn, Ian W. ; Kamdar, Manali ; Munir, Talha ; Walewska, Renata and Corbett, Gillian , et al. (2022) In Leukemia 36(4). p.1171-1175
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
publishing date
type
Contribution to journal
publication status
published
subject
in
Leukemia
volume
36
issue
4
pages
1171 - 1175
publisher
Nature Publishing Group
external identifiers
  • pmid:34974526
  • scopus:85122061347
ISSN
0887-6924
DOI
10.1038/s41375-021-01485-x
language
English
LU publication?
no
id
b7c705a9-eba0-4e83-bcbf-7874a056eb7e
date added to LUP
2022-03-03 15:07:48
date last changed
2024-06-27 12:21:13
@article{b7c705a9-eba0-4e83-bcbf-7874a056eb7e,
  author       = {{Sharman, Jeff P. and Egyed, Miklos and Jurczak, Wojciech and Skarbnik, Alan and Pagel, John M. and Flinn, Ian W. and Kamdar, Manali and Munir, Talha and Walewska, Renata and Corbett, Gillian and Fogliatto, Laura Maria and Herishanu, Yair and Banerji, Versha and Coutre, Steven and Follows, George and Walker, Patricia and Karlsson, Karin and Ghia, Paolo and Janssens, Ann and Cymbalista, Florence and Woyach, Jennifer A. and Ferrant, Emmanuelle and Wierda, William G. and Munugalavadla, Veerendra and Yu, Ting and Wang, Min Hui and Byrd, John C.}},
  issn         = {{0887-6924}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{1171--1175}},
  publisher    = {{Nature Publishing Group}},
  series       = {{Leukemia}},
  title        = {{Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia}},
  url          = {{http://dx.doi.org/10.1038/s41375-021-01485-x}},
  doi          = {{10.1038/s41375-021-01485-x}},
  volume       = {{36}},
  year         = {{2022}},
}